Trientine Hydrochloride

CAS 38260-01-4 10 current records 2 historicalSmall Molecule

Who holds supplier records for Trientine Hydrochloride? 10 organisations hold a current record for Trientine Hydrochloride: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (6), France (1), United States (1) and Netherlands (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Trientine Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/trientine-hydrochloride

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    6 of the 9 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Trientine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

India6France1United States1Netherlands1Country not recorded for 1
Need Trientine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (2)

Organisations whose Type II DMFs for Trientine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 2 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Trientine Hydrochloride is a chelating agent used to treat Wilson's disease, a condition in which excess copper builds up in the body. It binds to copper, allowing it to be excreted from the body via urine.

Chemical identity

IUPAC name
N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;dihydrochloride
Canonical SMILES
C(CNCCNCCN)N.Cl.Cl
InChIKey
WYHIICXRPHEJKI-UHFFFAOYSA-N
Synonyms
Syprine API, mk-0681, nsc-759164, syprine, trientine dihydrochloride, trientine hcl, triethylene tetramine dihydrochloride

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Copper Chelator; Metal Chelator
Mechanism of action
Copper Chelating Activity; Metal Chelating Activity

Therapeutic areas

HepatologyGenetic Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Trientine Hydrochloride?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Trientine Hydrochloride: BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), CHEMWERTH INC (France), COHANCE LIFESCIENCES LTD (India), CURIA NEW YORK INC, DASAMI LAB PRIVATE LTD (India), Emcure Pharmaceuticals Limited (India), MSN Organics Private Limited (India) and NAVINTA LLC (United States), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Trientine Hydrochloride Drug Master Files are active?

BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 29527), CHEMWERTH INC (DMF 29019), COHANCE LIFESCIENCES LTD (DMF 32956), CURIA NEW YORK INC (DMF 12659), DASAMI LAB PRIVATE LTD (DMF 34910), Emcure Pharmaceuticals Limited (DMF 31395), MSN Organics Private Limited (DMF 31085) and NAVINTA LLC (DMF 30905) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Trientine Hydrochloride records mean?

2 organisations have only inactive Type II DMFs for Trientine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Trientine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Trientine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.